ROBERT WEINSTEIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT WEINSTEIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT WEINSTEIN. ROBERT WEINSTEIN is Chief Financial Officer in ABLE LABORATORIES INC ($ABRX) and Vice President and C.F.O. in ABLE LABORATORIES INC ($ABRX) and Director in XpresSpa Group, Inc. ($XSPA) and See Remarks in Neurotrope, Inc. ($NTRP).
Latest Insider Trading Transactions of ROBERT WEINSTEIN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABRX, NTRP, XSPA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2021 | XSPA | XpresSpa Group, In ... | WEINSTEIN ROBERT | Director | Option Exercise | A | 1.19 | 43,077 | 51,262 | 43,077 | |
Jan 06 2021 | XSPA | XpresSpa Group, In ... | WEINSTEIN ROBERT | Director | Grant | A | 0.00 | 28,235 | 0 | 28,235 | 0 to 28.2 K |
Dec 03 2020 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | D | 0.97 | 135,000 | 131,220 | 0 | |
Dec 03 2020 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | D | 3.93 | 25,000 | 98,250 | 0 | |
Dec 03 2020 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | D | 19.62 | 18,945 | 371,701 | 0 | |
Dec 03 2020 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | D | 10.56 | 7,768 | 82,030 | 0 | |
Dec 03 2020 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | D | 25.60 | 3,125 | 80,000 | 0 | |
Dec 03 2020 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | D | 25.00 | 1,303 | 32,575 | 0 | |
Dec 03 2020 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | D | 32.00 | 20,313 | 650,016 | 0 | |
Dec 03 2020 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Sell | D | 0.00 | 3,953 | 0 | 0 | 4 K to 0 (-100.00 %) |
Nov 27 2020 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | A | 0.97 | 135,000 | 131,220 | 135,000 | |
Apr 21 2020 | XSPA | XpresSpa Group, In ... | WEINSTEIN ROBERT | Director | Option Exercise | A | 0.51 | 185,000 | 94,350 | 185,000 | |
Apr 21 2020 | XSPA | XpresSpa Group, In ... | WEINSTEIN ROBERT | Director | Option Exercise | A | 0.51 | 185,000 | 94,350 | 185,000 | |
Jan 24 2019 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | A | 3.93 | 25,000 | 98,250 | 25,000 | |
Apr 13 2017 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | A | 19.62 | 18,945 | 371,701 | 18,945 | |
Dec 20 2016 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | X | 0.01 | 41,667 | 417 | 0 | |
Dec 20 2016 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | X | 0.01 | 41,667 | 417 | 0 | |
Dec 20 2016 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Buy | X | 0.01 | 41,667 | 417 | 126,438 | 84.8 K to 126.4 K (+49.15 %) |
Dec 20 2016 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Buy | X | 0.01 | 41,667 | 417 | 84,771 | 43.1 K to 84.8 K (+96.67 %) |
Nov 23 2016 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | A | 0.33 | 248,548 | 82,021 | 248,548 | |
Nov 21 2016 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | C | 0.58 | 41,667 | 24,167 | 0 | |
Nov 21 2016 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Buy | C | 0.00 | 43,104 | 0 | 168,105 | 125 K to 168.1 K (+34.48 %) |
Nov 19 2015 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | A | 0.80 | 100,000 | 80,000 | 100,000 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | P | 1.50 | 41,667 | 62,501 | 41,667 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | P | 1.00 | 41,667 | 41,667 | 41,667 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | P | 1.25 | 41,667 | 52,084 | 41,667 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | P | 0.80 | 41,667 | 33,334 | 41,667 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | P | 0.80 | 41,667 | 33,334 | 41,667 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | WEINSTEIN ROBERT | See Remarks | Option Exercise | P | 0.00 | 417 | 0 | 41,667 | |
Sep 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Option Exercise | M | 8.30 | 1,000 | 8,300 | 31,500 | |
Sep 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Sell | S | 21.73 | 1,000 | 21,730 | 0 | 1,000 to 0 (-100.00 %) |
Sep 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Buy | M | 8.30 | 1,000 | 8,300 | 1,000 | 0 to 1,000 |
Sep 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Option Exercise | M | 8.30 | 1,000 | 8,300 | 31,500 | |
Sep 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Sell | S | 21.73 | 1,000 | 21,730 | 0 | 1,000 to 0 (-100.00 %) |
Sep 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Buy | M | 8.30 | 1,000 | 8,300 | 1,000 | 0 to 1,000 |
Jun 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Option Exercise | M | 8.30 | 2,500 | 20,750 | 32,500 | |
Jun 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Sell | S | 18.40 | 1,021 | 18,786 | 0 | 1 K to 0 (-100.00 %) |
Jun 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Sell | S | 18.42 | 1,479 | 27,243 | 1,021 | 2.5 K to 1 K (-59.16 %) |
Jun 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Buy | M | 8.30 | 2,500 | 20,750 | 2,500 | 0 to 2.5 K |
Apr 05 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Option Exercise | M | 8.30 | 5,000 | 41,500 | 35,000 | |
Apr 05 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Sell | S | 19.38 | 5,000 | 96,900 | 0 | 5 K to 0 (-100.00 %) |
Apr 05 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Buy | M | 8.30 | 5,000 | 41,500 | 5,000 | 0 to 5 K |
Feb 26 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Vice President and ... | Option Exercise | A | 17.15 | 25,000 | 428,750 | 25,000 | |
Feb 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Option Exercise | M | 8.30 | 5,000 | 41,500 | 40,000 | |
Feb 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Sell | S | 18.12 | 5,000 | 90,600 | 0 | 5 K to 0 (-100.00 %) |
Feb 03 2004 | ABRX | ABLE LABORATORIES ... | WEINSTEIN ROBERT | Chief Financial Off ... | Buy | M | 8.30 | 5,000 | 41,500 | 5,000 | 0 to 5 K |
Page: 1